R1 RCM to Present at the KeyBanc Life Sciences & MedTech Investor Forum
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
R1 RCM announced that its management will present at the KeyBanc Life Sciences & MedTech Investor Forum on March 23, 2021, at 10:45 am ET. The event will be accessible via a live audio webcast on R1's Investor Relations website, with a replay available for 90 days post-event. As a leader in technology-driven solutions, R1 RCM enhances patient experiences and financial performance for healthcare providers, focusing on improving net patient revenue and reducing operational costs.
Details
News Market Reaction – RCM
The recorded move for RCM in the trading session of this news was +1.91%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHICAGO, March 09, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 23 at 10:45am ET.
A live audio webcast of the presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webcast will be available for 90 days following the live webcast.
About R1 RCM
R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com.
Contact:
R1 RCM Inc.
Investor Relations:
Atif Rahim
312-324-5476
investorrelations@r1rcm.com
Media Relations:
Natalie Joslin
R1 RCM Inc.
678.585.1206
media@r1rcm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.